Related Experiment Video
Updated: Feb 15, 2026

Foraging Path-length Protocol for Drosophila melanogaster Larvae
Published on: April 23, 2016
[Continued development of drugs: the path of thioguanine]
M Simsek1, N K H de Boer, C J J Mulder
1VUmc, afd. Maag-, darm- en leverziekten, Amsterdam.
Abstract:
Continued development of existing drugs ('drug rediscovery') may offer new therapeutic options and be cost-effective. Rediscovered drugs are commonly prescribed off-label, although licensing can be important to allow safe and controlled prescription of the drugs to patients. Licensing of a new indication for a generic drug, however, is a complicated process since there is no blueprint for this and there is little interest from the pharmaceutical industry due to an unattractive cost-recovery model. In this article, we illustrate the successful license-extension for thioguanine - initially developed in 1950 for leukaemia - as a new treatment for patients with inflammatory bowel disease.
More Related Videos
07:23Author Spotlight: Developing a Simple and Robust Hepatic Model for Pharmacological and Toxicological Applications
Published on: October 20, 2023
07:02A Computerized Test Battery to Study Pharmacodynamic Effects on the Central Nervous System of Cholinergic Drugs in Early Phase Drug Development
Published on: February 11, 2019
Related Concept Videos
Mean free path and Mean free time
Path Between Thermodynamics States
Behavior of Gas Molecules: Molecular Diffusion, Mean Free Path, and Effusion
Interference: Path Lengths
Two special sources may be considered when they are in phase. This can be easily achieved by feeding the two sources from the same source. An example would be synchronizing the two speakers by feeding them with the same source, such as the sound waves produced by a tuning fork. This setup ensures that the two sources have the same frequency and are...
Oral Drug Delivery Systems: Continuous-Release Systems
Extracorporeal Removal of Drugs: Continuous Renal Replacement Therapy